Clinical Trial Update: Cross-linked Hyaluronic Acid/dextranomer for the Treatment of Stress Urinary Incontinence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating cross-linked hyaluronic acid/dextranomer for treating stress urinary incontinence; recruitment has not started yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Cross-linked hyaluronic acid/dextranomer (dextranomer in hyaluronic acid (cross-linked))

Snippet

Sponsor: Izmir Bakircay University | Conditions: Urinary Stress Incontinence (SI) | Phase 2 | Status: NOT_YET_RECRUITING